Sign in →

Test Code NGSBM OncoScreen ST Solid Tumor Panel (Bone Marrow)

Specimen and Container/Tube

Bone Marrow

Rejection Criteria

Inappropriate anticoagulant and >72 hours

Turnaround Time

Not Available

Test Includes

Detects hot spot regions of 50 commonly mutated genes in
cancer.
The genes are:ABL1, AKT1, ALK,
APC,
ATM,
BRAF, CDH1,
CDKN2A, CSF1R, CTNNB1,
EGFR, ERB2,
ERBB4, EZH2, FBXW7, FGFR1,
FGFR2, FGFR3, FLT3, GNA11, GNAQ,
GNAS, HNF1A,
HRAS, IDH1,
IDH2, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1,
MPL, NOTCH1,
NPM1, NRAS,
PDGFRA,
PIK3CA,
PTEN, PTPN11,
RB1, RET,
SMAD4, SMARCB1, SMO,
SRC, STK11,
TP53, VHL.

Specimen Type

Bone Marrow

Preferred Volume

2 mL

Fee Code

376540-30181450

Offsite Collection Instructions

Send within 24 hours or Refrigerate/ send within 72 hours

Test Usage

Targeted and rapid assay for genomic profiling of solid
tumor
and hematological malignancy specimens to determine appropriate
therapies. It also can be useful for diagnosis, prognosis,
clinical
trials selection and for translational research.

UCMC Collection Instructions

Send within 72 hours

Test Limitations

Will not detect mutations below the analytical sensitivity
of
the assay (5% variant allelic frequency).

Synonyms

None

STAT Turnaround Time

Not Available

Container/Tube

Lavender top

Specimen Minimum Volume

0.5 mL

Special Instructions

Send within 72 hours

Day(s) Performed

Monday – Friday, 8:00 AM – 4:30 PM

STAT DAY(S) AND TIME(S) PERFORMED

No

CPT

81450

Method Name

Next Generation Sequencing

Reference Values

Interpretative report

Reject Due To

Inappropriate anticoagulant and >72 hours

Pediatric Volume

0.5 mL

Clinical Indications

Targeted and rapid assay for genomic profiling of solid
tumor
and hematological malignancy specimens to determine appropriate
therapies. It also can be useful for diagnosis, prognosis,
clinical
trials selection and for translational research.

Transport Instructions

Send within 24 hours or Refrigerate/ send within 72 hours

Test Components

Detects hot spot regions of 50 commonly mutated genes in
cancer.
The genes are:ABL1, AKT1, ALK,
APC,
ATM,
BRAF, CDH1,
CDKN2A, CSF1R, CTNNB1,
EGFR, ERB2,
ERBB4, EZH2, FBXW7, FGFR1,
FGFR2, FGFR3, FLT3, GNA11, GNAQ,
GNAS, HNF1A,
HRAS, IDH1,
IDH2, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1,
MPL, NOTCH1,
NPM1, NRAS,
PDGFRA,
PIK3CA,
PTEN, PTPN11,
RB1, RET,
SMAD4, SMARCB1, SMO,
SRC, STK11,
TP53, VHL.

Methodology

Next Generation Sequencing

Synonyms/Key Search Words

None